top of page




King’s College London and Pioneer Group in incubator link-up
Pioneer Group has announced a partnership with King’s College London to launch new dedicated start-up incubators in biotech and medtech on t

QUANTUNG PHARMA


BeiGene Ups ADC Investment with $1.3B DualityBio Licensing Deal
Chinese biotech BeiGene has acquired an exclusive license of an investigational antibody-drug conjugate for $1.3 billion from Shanghai-based

QUANTUNG PHARMA


Edinburgh researchers and LifeArc to boost MND treatment processes
A project involving researchers based in Edinburgh wants to establish effective combinations of existing drugs which, used together, could t

QUANTUNG PHARMA


TME Pharma reveals positive NOX-A12 data
GLORIA trial shows increased survival levels among newly diagnosed brain cancer patients
TME Pharma – a company concentrating on the develo

QUANTUNG PHARMA


Digital Health London’s Accelerator programme selects Aide
Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions

QUANTUNG PHARMA


University of Oxford and PrecisionLife reach data agreement
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis

QUANTUNG PHARMA


Genfit and Ipsen announce elafibranor results
ELATIVE, a randomised PBC trial involving 161 patients, has successfully met its primary endpoint

QUANTUNG PHARMA


Teva reveals critical Ajovy data
Therapy has been developed to reduce the frequency, duration and severity of migraine attacks

QUANTUNG PHARMA


Momentum for Poolbeg and CytoReason’s AI collaboration
Partnership establishes several influenza therapy targets using artificial intelligence

QUANTUNG PHARMA


Novartis reveals five-year efficacy data for Kesimpta
Patients treated with Kesimpta experienced considerable decreases in relapse rates

QUANTUNG PHARMA


GeneCode receives record Parkinson’s funding
European Innovation Council Accelerator finances treatment development drive for condition

QUANTUNG PHARMA


Positive efficacy data for Sensorian’s candidate I QUANTUNG Pharma
SENS-401 has been developed for hearing preservation among adult patients following cochlear implantation

QUANTUNG PHARMA


Biotech firms target weight-loss drugs without Wegovy's side-effects
Biotech firms target weight-loss drugs without Wegovy's side-effects, QUNATUNG Pharma

QUANTUNG PHARMA


Incyte’s Opzelura gets MHRA authorisation
Incyte Biosciences has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted marketing authorisation for

QUANTUNG PHARMA


Vertex’s Orkambi receives EC approval I QUANTUNG Pharma
Orkambi is an oral treatment for very young children that combines both lumacaftor and ivacaftor

QUANTUNG PHARMA


Novavax COVID-19 vaccine produces immunity
Researchers leading the University of Oxford’s Com-COV3 study have delivered results from a study researching the immune response and side-e

QUANTUNG PHARMA


em que pé está a canábis medicinal em Portugal?
Conheça os contornos deste novo método medicinal, o que é legal em Portugal e as diferentes opiniões quanto à sua utilização, neste espaço d

QUANTUNG PHARMA


Canábis em Portugal
A canábis em Portugal foi descriminalizada em 2001, quando a posse de todas as drogas ilícitas foi descriminalizada no país, sendo as sançõe

QUANTUNG PHARMA


Canábis para fins medicinais
A Lei n.º 33/2018, de 18 de julho, estabeleceu o quadro legal para a utilização de medicamentos, preparações e substâncias à base da planta

QUANTUNG PHARMA


Global cannabis testing market to grow 13.4% through 2025
The latest news on health and medicine, covid, vaccines, global health, mental health, Obamacare, health insurance, Medicare, Medicaid, opio

QUANTUNG PHARMA
bottom of page